Abstract: The present invention discloses a composition comprising a compound of formula I and a deuterated solvent. The deuterated solvent is miscible with water in any proportion at a temperature of 20 to 25° C. and comprises less than 5% residual 1H-isotopes. The concentration of the compound of formula I may advantageously be determined by 1H-QNMR. Methods of production of the composition and salts of compounds of formula I, as well as related analogs and novel reagents and intermediates for the production thereof, are also described.

Abstract: The present invention discloses a composition comprising a compound of formula I and a deuterated solvent. The deuterated solvent is miscible with water in any proportion at a temperature of 20 to 25° C. and comprises less than 5% residual 1H-isotopes. The concentration of the compound of formula I may advantageously be determined by 1H-QNMR. Methods of production of the composition and salts of compounds of formula 1, as well as related analogs and novel reagents and intermediates for the production thereof, are also described.

Abstract: The present invention discloses a composition comprising a compound of formula I and a deuterated solvent. The deuterated solvent is miscible with water in any proportion at a temperature of 20 to 25° C. and comprises less than 5% residual 1H-isotopes. The concentration of the compound of formula I may advantageously be determined by 1H-QNMR. Methods of production of the composition and salts of compounds of formula I, as well as related analogs and novel reagents and intermediates for the production thereof, are also described.

Abstract: The present invention discloses a composition comprising a compound of formula I and a deuterated solvent. The deuterated solvent is miscible with water in any proportion at a temperature of 20 to 25° C. and comprises less than 5% residual 1H-isotopes. The concentration of the compound of formula I may advantageously be determined by 1H-QNMR. Methods of production of the composition and salts of compounds of formula I, as well as related analogs and novel reagents and intermediates for the production thereof, are also described.

Abstract: An improved method for assessing previous ethanol exposure comprises the steps of obtaining a sample from the body of a subject; quantitatively determining the level of one or several bio-precursors of phosphatidylethanol (PEth) (Formula I) or ethyl-sphingomyelin and the level of the corresponding one or several PEth (Formula II) or ethyl-sphingomyelin homologues in the sample; and obtaining a ratio between the level of one or several bio-precursors of PEth or ethyl-sphingomylein and the level of the corresponding one or several PEth- or ethyl-sphingomylein homologues. The ratio is indicative of previous ethanol consumption of the subject. Furthermore, a method for assessing previous absolute ethanol consumption can be accomplished by correlating the ratios of PEth precursor and PEth homologue levels in subjects to ratios obtained from reference subjects with known previous ethanol consumption.